MAP 2018 – Molecular Analysis for Personalised Therapy Congress

The development of new biotechnologies and their application to precision medicine in cancer treatment is a fast-moving field. Understanding molecular alterations, their mechanisms of action and how they can apply to therapy is a challenge in medical oncology and clinical practice.

MAP 2018, in Paris, France, on September 14-15th, will be the place for Medical Oncologists and stake holders to acquire the most recent knowledge in precision medicine. 

Learning objectives

  • Therapeutics targets in various tumour types and the use of genomic profiling for treatment selection
  • Clonal evolution
  • Use of mathematical modelling and artificial intelligence as tools for disease evolution
  • The impact of micro satellite instability testing across tumour types
  • The role of virus in carcinogenesis and the impact of gut microbiota in immune treatment efficacy
  • The development of precision immuno-oncology
  • The design of innovative trials for better outcome achievements 


MAP 2018

September 14-15th

Marriott Rive Gauche Hotel & Conference Centre, Paris, France



More information


Early registration until 4 July 2018     

Late registration until 22 August 2018     

Full registration from 23 August 2018


Abstract submission

From 20 February 2018, to 5 July 2018, 21:00 CET (Central European Time)